RUNX1 and metabolic dysfunction-associated steatotic liver disease: This may be because in earlier studies, they solely analyzed RUNX1 in the HSCs and in our study, we focused on endothelial-specific expression of RUNX1 and its potential role in NAFLD pathogenesis.